The genes ACSL4, ATF3, CAT, GSTM5 and NR0B2 were previously described in fatty liver disease [20], [21] and served as positive controls for the quantitative validation of candidate genes in the present study. This evidence concerns the gene NR0B2 and fatty liver disease.